Clinical trial TK-SCR-01
Assessing Frequency of HLA-Genotypes and Tumor Antigen Expression in Subjects with Relapsed/Refractory, Advanced-Stage Solid Tumors that may Qualify for Novel T Cell Receptor Based Therapies
| Organ | Multiple |
|---|---|
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Prospective observational study
|
| Academic trial | Non |
| Sponsor | T-Knife GmbH |
| BECT Identifier | B6702021000737 |
| Last update |